Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Revenue (2016 - 2025)

Historic Revenue for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $402.1 million.

  • Integra Lifesciences Holdings' Revenue rose 557.41% to $402.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 498.72%. This contributed to the annual value of $1.6 billion for FY2024, which is 447.3% up from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Revenue of $402.1 million as of Q3 2025, which was up 557.41% from $415.6 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Revenue registered a high of $442.6 million during Q4 2024, and its lowest value of $360.1 million during Q1 2021.
  • Over the past 5 years, Integra Lifesciences Holdings' median Revenue value was $386.9 million (recorded in 2021), while the average stood at $392.2 million.
  • As far as peak fluctuations go, Integra Lifesciences Holdings' Revenue skyrocketed by 5077.11% in 2021, and later tumbled by 415.97% in 2023.
  • Integra Lifesciences Holdings' Revenue (Quarter) stood at $405.5 million in 2021, then dropped by 1.85% to $398.0 million in 2022, then decreased by 0.25% to $397.0 million in 2023, then grew by 11.49% to $442.6 million in 2024, then fell by 9.17% to $402.1 million in 2025.
  • Its last three reported values are $402.1 million in Q3 2025, $415.6 million for Q2 2025, and $382.7 million during Q1 2025.